Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis

Amy Paller (Creator)
E. Siegfried (Creator)
M. Cork (Creator)
A. Wollenberg (Creator)
Peter D. Arkwright (Contributor)
Mercedes Gonzalez (Creator)
Benjamin Lockshin (Creator)
Zhen Chen (Creator)
Ashish Bansal (Creator)
Noah A. Levit (Creator)
Randy Prescilla (Creator)

Dermatology

Dataset

1 Article

1 results

2023
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
Paller, A. S., Siegfried, E. C., Cork, M. J., Wollenberg, A., Arkwright, P. D., Gonzalez, M. E., Lockshin, B., Chen, Z., Bansal, A., Levit, N. A. & Prescilla, R., Jan 2023, In: Pediatric Drugs. 25, 1, p. 67-77 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
10 Scopus citations